Novocure Ltd (NVCR:NASDAQ)
$13.04 -1.19 (-8.36%)
Analysed Novocure Ltd (NVCR:NASDAQ) News Sources
Japan’s MHLF approves reimbursement for Novocure’s Optune Lua to treat non-small cell lung cancer
Pharmabiz
Novocure has reimbursement win for Optune Lua in Japan
MassDevice
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
Yahoo Finance
A Look At NovoCure (NVCR) Valuation As Record 2025 Results And Optune Pax Approval Reset Growth Expectations
Yahoo Finance
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Le Lézard
KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
Le Lézard
What is the current price of Novocure Ltd (NVCR:NASDAQ)?
The current price of Novocure Ltd (NVCR:NASDAQ) is $13.04.
Novocure Ltd (NVCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of Novocure Ltd (NVCR:NASDAQ) since the previous trading day is $-1.19.
Novocure Ltd (NVCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of Novocure Ltd (NVCR:NASDAQ) since the previous trading day is -8.36%.
What is This Week's average sentiment score for Novocure Ltd (NVCR:NASDAQ)?
This Week's average sentiment score for Novocure Ltd (NVCR:NASDAQ) is 88 out of 100.
What is This Week's average sentiment for Novocure Ltd (NVCR:NASDAQ)?
This Week's sentiment for Novocure Ltd (NVCR:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.